Zur Hauptnavigation wechseln
Zur Suche wechseln
Zum Hauptinhalt wechseln
sortieren
Keyphrases
Multiple Sclerosis
100%
Disease Pathogenesis
33%
Older Adults
16%
Germany
16%
Genetic Factors
16%
Multiple Sclerosis Treatment
16%
Epidemiological Study
16%
Environmental Factors
16%
Targeting Mechanism
16%
Therapeutic Strategies
16%
Experimental Animal Models
16%
Immunosuppressive Therapy
16%
Severe Disabilities
16%
Mitoxantrone
16%
Disease Mechanisms
16%
Target Antigen
16%
Phase I Study
16%
Most Common Cause
16%
Tissue Destruction
16%
Immunomodulatory Therapy
16%
Autoimmune Process
16%
Family Study
16%
Glatiramer Acetate
16%
Chronic Inflammatory Demyelinating
16%
Central Nervous System Demyelinating Diseases
16%
Demyelinating Disease
16%
Interferon-beta (IFN-β)
16%
Pharmacology, Toxicology and Pharmaceutical Science
Multiple Sclerosis
100%
Diseases
42%
Pathogenesis
42%
Mitoxantrone
14%
Experimental Animal
14%
Glatiramer
14%
Prevalence
14%
Immunosuppressive Agent
14%
Beta Interferon
14%
Demyelinating Disease
14%
Antigen
14%
Immunology and Microbiology
Multiple Sclerosis
100%
Antigen
16%
Autoimmunity
16%
Immunosuppressive Therapy
16%
Treatment of Multiple Sclerosis
16%
Glatiramer Acetate
16%
Central Nervous System
16%
Prevalence
16%
Experimental Animal
16%
Beta Interferon
16%
Clinically Isolated Syndrome
16%